Hosted on MSN

Bio-Gene Secures $519,500 R&D Tax Incentive for Innovative Insecticides

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
GEN

Form Bio’s AI Ensures Gene Therapies Pass Muster, with Ginkgo’s Help

The cell and gene therapy field is, some say, at a tipping point—poised to take off. The FDA has noted that, by next year, they aim to approve 10–20 new cell and gene therapies per year. To do that, ...
Nasdaq

Bio-Gene Technology Announces Successful AGM Resolutions

Bio-Gene Technology Ltd. announced that all resolutions were passed at their 2024 Annual General Meeting, highlighting investor confidence in their strategic direction. The company is known for ...
Benzinga.com

Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy

Newly released data reveals that seven out of 67 children treated with Bluebird Bio Inc's (NASDAQ:BLUE) gene therapy for a severe neurological disorder in clinical trials have developed blood cancers.
The Business Journals

Moderna-partnered gene therapy firm to lay off 68, including two execs

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An Atlas Venture-backed startup ...
Nasdaq

Ocugen, Inc. to Present at 2025 BIO International Convention, Showcasing Gene Therapy Advancements for Blindness Diseases

Ocugen, Inc. announced its participation in the 2025 BIO International Convention in Boston, taking place from June 16-19. The company will present their innovative modifier gene therapy platform that ...